| Induction of c-myc oncoprotein and of cellular proliferation by radiation in normal human urothelial cultures. | None |
| The PVT-1 oncogene is a Myc protein target that is overexpressed in transformed cells. | None |
| c-myc oncoprotein function. | None |
| Myc goes global: new tricks for an old oncogene. | None |
| The small Rho GTPase Rac1 controls normal human dermal fibroblasts proliferation with phosphorylation of the oncoprotein c-myc. | None |
| findings identify a critical function of c-Myc in DNA replication and suggest a novel mechanism for its normal and oncogenic functions | None |
| Suppression of oncogenic properties of c-Myc by LKB1-controlled epithelial organization. | None |
| Suppression of oncogenic properties of c-Myc by LKB1-controlled epithelial organization. | None |
| Review describes a microRNA cluster induced by oncogenic transcription factor c-myc that is implicated in inhibiting proliferation, as well as inhibiting apoptosis and promoting angiogenesis. | None |
| Nuclear receptor hepatocyte nuclear factor 4alpha1 competes with oncoprotein c-Myc for control of the p21/WAF1 promoter. | None |
| Growth hormone receptor (Ghr) and hemoglobin alpha-chain pseudogene 3 (Hba-ps3) map proximal to the myelocytomatosis oncogene (Myc) on mouse chromosome 15. | None |
| [Regulatory protein factor CTCF interacts with a segment of the chicken c-myc oncogene promotor, capable of changing to a noncanonical conformation]. | None |
| Circular dichroism study of DNA binding by a potential anticancer peptide nucleic acid targeted against the MYCN oncogene. | None |
| [The regulation of DNA repair processes in mammalian cells. II. The repair of DNA radiation damage in NIH 3T3 murine cells transformed by the v-myc oncogene]. | None |
| STAGA recruits Mediator to the MYC oncoprotein to stimulate transcription and cell proliferation. | None |
| Both Wnt and mTOR signaling pathways are involved in insulin-stimulated proto-oncogene expression in intestinal cells. | None |
| Concurrent gain of 17q and the MYC oncogene in a medullomyoblastoma. | None |
| Antibodies to sperm surface antigens and the c-myc proto-oncogene product inhibit early embryonic development in mice. | None |
| Dynamic regulation of c-Myc proto-oncogene expression during lymphocyte development revealed by a GFP-c-Myc knock-in mouse. | None |
| The Jak2V617F oncogene associated with myeloproliferative diseases requires a functional FERM domain for transformation and for expression of the Myc and Pim proto-oncogenes. | None |